基于数据挖掘的中医治疗新型冠状病毒肺炎用药特点分析
[Analysis of medication characteristics of traditional Chinese medicine in treating COVID-19 based on data mining].
作者信息
Fan Tiantian, Chen Yongcan, Bai Yu, Ma Fengqi, Wang Hengcang, Yang Yiping, Chen Jinxu, Lin Yuqi
机构信息
College of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Tongde Hospital of Zhejiang Province, Hangzhou 310007, China.
出版信息
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25;49(2):260-269. doi: 10.3785/j.issn.1008-9292.2020.03.14.
OBJECTIVE
To analysis the medication characteristics of the prescriptions issued via open channel by the National and Provincial Health Committee and the State Administration of Traditional Chinese Medicine in treating coronavirus disease 2019 (COVID-19).
METHODS
We collected the data of traditional Chinese medicine related to treatment plans published by the National and Provincial Health Committee and the State Administration of Traditional Chinese Medicine from the start of COVID-19 outbreak to February 19, 2020. The frequency analysis, cluster analysis and association analysis were performed.
RESULTS
The study collected 4 national and 34 regional prevention and treatment plans, 578 items, 84 traditional Chinese formulations, 60 Chinese patent medicines, and 230 Chinese herbs. The high frequently used herbs were , and . The commonly used traditional formulations included decoction, powder, and decoction. The Chinese patent drugs included pill, injection, and capsule. The most common paired medications were and and Two core combinations and one novel formula were discovered in the study.
CONCLUSIONS
powder and decoction are the basic formulations for syndrome of COVID-19. In addition, decoction, powder, decoction and decoction are the basic formulations for syndrome of COVID-19. The main medication characteristics are clearing heat, entilating lung, removing toxicity and removing turbidity. It shows that removing toxicity and eliminating evil are the prescription thought in treating epidemic disease of traditional Chinese medicine.
目的
分析国家和省级卫生健康委以及国家中医药管理局通过公开渠道发布的治疗新型冠状病毒肺炎（COVID-19）处方的用药特点。
方法
收集自COVID-19疫情暴发至2020年2月19日国家和省级卫生健康委以及国家中医药管理局发布的与治疗方案相关的中医药数据，进行频次分析、聚类分析和关联分析。
结果
本研究收集了4个国家级和34个地区级防治方案，共578项，84个中药方剂，60种中成药，230味中药。高频使用的中药有 、 和 。常用的中药方剂有 汤、 散和 汤。中成药有 丸、 注射液和 胶囊。研究发现最常见的配对药物是 与 以及 ，还发现了两个核心组合和一个新方剂。
结论
散和 汤是COVID-19 证的基本方剂。此外， 汤、 散、 汤和 汤是COVID-19 证的基本方剂。主要用药特点为清热、宣肺、解毒、化浊。表明解毒祛邪是中医治疗疫病的处方思路。
需注意，原文中部分草药名称缺失，翻译时用“ ”代替了。
Zotero 插件